BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30213761)

  • 1. Systemic lupus erythematosus: A new autoimmune disorder in Kabuki syndrome.
    Arsov T; Sestan M; Cekada N; Frkovic M; Andrews D; He Y; Shen N; Vinuesa CG; Jelusic M
    Eur J Med Genet; 2019 Jun; 62(6):103538. PubMed ID: 30213761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.
    Bögershausen N; Gatinois V; Riehmer V; Kayserili H; Becker J; Thoenes M; Simsek-Kiper PÖ; Barat-Houari M; Elcioglu NH; Wieczorek D; Tinschert S; Sarrabay G; Strom TM; Fabre A; Baynam G; Sanchez E; Nürnberg G; Altunoglu U; Capri Y; Isidor B; Lacombe D; Corsini C; Cormier-Daire V; Sanlaville D; Giuliano F; Le Quan Sang KH; Kayirangwa H; Nürnberg P; Meitinger T; Boduroglu K; Zoll B; Lyonnet S; Tzschach A; Verloes A; Di Donato N; Touitou I; Netzer C; Li Y; Geneviève D; Yigit G; Wollnik B
    Hum Mutat; 2016 Sep; 37(9):847-64. PubMed ID: 27302555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel KMT2D mutation resulting in Kabuki syndrome: A case report.
    Lu J; Mo G; Ling Y; Ji L
    Mol Med Rep; 2016 Oct; 14(4):3641-5. PubMed ID: 27573763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic expansion of KMT2D-related disorder: Beyond Kabuki syndrome.
    Baldridge D; Spillmann RC; Wegner DJ; Wambach JA; White FV; Sisco K; Toler TL; Dickson PI; Cole FS; Shashi V; Grange DK
    Am J Med Genet A; 2020 May; 182(5):1053-1065. PubMed ID: 32083401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update of the genotype and phenotype of KMT2D and KDM6A by genetic screening of 100 patients with clinically suspected Kabuki syndrome.
    Murakami H; Tsurusaki Y; Enomoto K; Kuroda Y; Yokoi T; Furuya N; Yoshihashi H; Minatogawa M; Abe-Hatano C; Ohashi I; Nishimura N; Kumaki T; Enomoto Y; Naruto T; Iwasaki F; Harada N; Ishikawa A; Kawame H; Sameshima K; Yamaguchi Y; Kobayashi M; Tominaga M; Ishikiriyama S; Tanaka T; Suzumura H; Ninomiya S; Kondo A; Kaname T; Kosaki K; Masuno M; Kuroki Y; Kurosawa K
    Am J Med Genet A; 2020 Oct; 182(10):2333-2344. PubMed ID: 32803813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploinsufficiency of KMT2D is sufficient to cause Kabuki syndrome and is compatible with life.
    Luperchio TR; Applegate CD; Bodamer O; Bjornsson HT
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1072. PubMed ID: 31814321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the Oro-Dental and Mutational Spectra of Kabuki Syndrome and Expression of
    Porntaveetus T; Abid MF; Theerapanon T; Srichomthong C; Ohazama A; Kawasaki K; Kawasaki M; Suphapeetiporn K; Sharpe PT; Shotelersuk V
    Int J Biol Sci; 2018; 14(4):381-389. PubMed ID: 29725259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kabuki syndrome: novel pathogenic variants, new phenotypes and review of literature.
    Shangguan H; Su C; Ouyang Q; Cao B; Wang J; Gong C; Chen R
    Orphanet J Rare Dis; 2019 Nov; 14(1):255. PubMed ID: 31727177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging in Kabuki syndrome and another KMT2D-related disorder.
    Stadelmaier RT; Kenna MA; Barrett D; Mullen TE; Bodamer O; Agrawal PB; Robson CD; Wojcik MH
    Am J Med Genet A; 2021 Dec; 185(12):3770-3783. PubMed ID: 34369642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.
    Lindsley AW; Saal HM; Burrow TA; Hopkin RJ; Shchelochkov O; Khandelwal P; Xie C; Bleesing J; Filipovich L; Risma K; Assa'ad AH; Roehrs PA; Bernstein JA
    J Allergy Clin Immunol; 2016 Jan; 137(1):179-187.e10. PubMed ID: 26194542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Holoprosencephaly in Kabuki syndrome.
    Daly T; Roberts A; Yang E; Mochida GH; Bodamer O
    Am J Med Genet A; 2020 Mar; 182(3):441-445. PubMed ID: 31846209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.
    Yap CS; Jamuar SS; Lai AHM; Tan ES; Ng I; Ting TW; Tan EC
    Gene; 2020 Mar; 731():144360. PubMed ID: 31935506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kabuki syndrome with midgut malrotation and hyperinsulinemic hypoglycemia: A rare co-occurrence from Thailand.
    Phetthong T; Tim-Aroon T; Khongkrapan A; Poomthavorn P; Wattanasirichaigoon D
    Am J Med Genet A; 2020 Aug; 182(8):1873-1876. PubMed ID: 32525229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHARGE and Kabuki syndromes: a phenotypic and molecular link.
    Schulz Y; Freese L; Mänz J; Zoll B; Völter C; Brockmann K; Bögershausen N; Becker J; Wollnik B; Pauli S
    Hum Mol Genet; 2014 Aug; 23(16):4396-405. PubMed ID: 24705355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [One novel pathologic variation in
    Qiu SW; Yuan YY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):820-824. PubMed ID: 31446696
    [No Abstract]   [Full Text] [Related]  

  • 16. The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series.
    Wang Y; Li N; Su Z; Xu Y; Liu S; Chen Y; Li X; Shen Y; Hung C; Wang J; Wang X; Bodamer O
    Am J Med Genet A; 2020 Apr; 182(4):640-651. PubMed ID: 31883305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population.
    Faundes V; Malone G; Newman WG; Banka S
    J Hum Genet; 2019 Feb; 64(2):161-170. PubMed ID: 30459467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Patient with Kabuki Syndrome Mutation Presenting with Very Severe Aplastic Anemia.
    Tamura S; Kosako H; Furuya Y; Yamashita Y; Mushino T; Mishima H; Kinoshita A; Nishikawa A; Yoshiura KI; Sonoki T
    Acta Haematol; 2022; 145(1):89-96. PubMed ID: 34515044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance.
    Aref-Eshghi E; Schenkel LC; Lin H; Skinner C; Ainsworth P; Paré G; Rodenhiser D; Schwartz C; Sadikovic B
    Epigenetics; 2017; 12(11):923-933. PubMed ID: 28933623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration.
    Schwenty-Lara J; Nehl D; Borchers A
    Hum Mol Genet; 2020 Jan; 29(2):305-319. PubMed ID: 31813957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.